Authors reply: Clinical presentation, course, and prognosis of patients with mixed connective tissue disease

Kevin Chevalier^{1

2}, Benjamin Chaigne^{1

2}, Luc Mouthon^{1

2}

Affiliations

¹ Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes et Autoinflammatoires Rares d'Ile de France de l'Est et de l'Ouest, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
² APHP-CUP, Hôpital Cochin, Université Paris Cité, Paris, France.

Comment

Kevin Chevalier et al. J Intern Med. 2024 Apr.

. 2024 Apr;295(4):576-578.

doi: 10.1111/joim.13765. Epub 2024 Jan 4.

Kevin Chevalier^{1

2}, Benjamin Chaigne^{1

2}, Luc Mouthon^{1

2}

¹ Service de Médecine Interne, Centre de Référence Maladies Systémiques Autoimmunes et Autoinflammatoires Rares d'Ile de France de l'Est et de l'Ouest, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
² APHP-CUP, Hôpital Cochin, Université Paris Cité, Paris, France.

No abstract available

Comment on

Regarding: Clinical presentation, course, and prognosis of patients with mixed connective tissue disease.
Dechosal A, Le Tallec E, Belhomme N, Lescoat A. Dechosal A, et al. J Intern Med. 2024 Apr;295(4):574-575. doi: 10.1111/joim.13766. Epub 2024 Jan 4. J Intern Med. 2024. PMID: 38178565 No abstract available.

1. Chevalier K, Thoreau B, Michel M, Godeau B, Agard C, Papo T, et al. Clinical presentation, course, and prognosis of patients with mixed connective tissue disease: a multicenter retrospective cohort. J Intern Med. 2024;295:532-543.
1. van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative: ACR/EULAR classification criteria for SSc. Arthritis Rheum. 2013;65:2737-2747.
1. Dima A, Jurcut C, Baicus C. The impact of anti-U1-RNP positivity: systemic lupus erythematosus versus mixed connective tissue disease. Rheumatol Int. 2018;38:1169-1178.
1. Ben Brahim M, Daada S, Olfa J, Jguirim M, Chaabene I, Kechida M, et al. Significations cliniques des anticorps anti-RNP au course du lupus érythémateux systémique. Rev Med Interne. 2021;42:A106-A107.
1. Wesner N, Uruha A, Suzuki S, Mariampillai K, Granger B, Champtiaux N, et al. Anti-RNP antibodies delineate a subgroup of myositis: a systematic retrospective study on 46 patients. Autoimmun Rev. 2020;19:102465.